Jiangsu Vcare Pharmaceutical Technology Co., Ltd

This early-stage trial is testing an experimental oral medication called VC005 in adolescents aged 12 to 18 with severe alopecia areata, a condition that causes patchy or complete hair loss. The study aims to understand how the drug is processed by the body, whether it is safe, a…

This trial is testing an experimental oral medication, VC005, in adults with severe alopecia areata—an autoimmune condition that causes patchy or complete hair loss. Participants will take either VC005 or a placebo daily for 24 weeks. The main goal is to see if the drug can reduc…

This trial tests an experimental drug called VC004 for people with moderate-to-severe pain caused by cancer that has spread to the bones. About 26 adults will receive either a low or high dose of VC004 or a placebo capsule, and researchers will track changes in daily pain scores …